The diagnosis of epilepsies

Journal of the Royal College of Physicians of London

Volumn 30, Issue 2, 1996, Pages 122-127

  Grunewald R A ^a   Panayiotopoulos, C P ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; VALPROIC ACID; VIGABATRIN;

ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; PATIENT CARE; REVIEW;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEUROLOGIC EXAMINATION; PROGNOSIS; SYNDROME;

EID: 0030004272     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Commission on classification and terminology of the International League against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
2. Grünewald RA, Chroni E. Panayiotopoulos CP. Delayed diagnosis of juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 1992;55:497-9.
3. Panayiotopoulos CP, Chroni E, Daskalopoulos C, Raker A, et al. Typical absence seizures in adults: clinical, EEG, video-EEG findings and diagnostic/syndromic considerations. J Neurol Neurosurg Psychiatry 1992;55:1002-8.
4. Commission on classification and terminology of the International League against Epilepsy. Proposed revisions of clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:480-501.
5. Panayiotopoulos CP (editorial). Benign childhood partial epilepsies: benign childhood seizure susceptibility syndromes. J Neurol Neurosurg Psychiatry 1993;56:2-5.
6. Grünewald RA, Panayiotopoulos CP. Juvenile myoclonic epilepsy: a review. Arch Neurol 1993;50:594-6.
7. Juvenile myoclonic epilepsy (editorial). Lancet 1992;340:759-60.
8. Leppert M, Anderson VE, Quattlebaum T, Stauffer D, et al. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 1989;337:647-8.
9. Lewis TB, Leach RJ, Ward K, O'Connell P, Ryan SG. Genetic heterogeneity in benign neonatal familial convulsions: identification of a new locus on chromosome 8q. Aw J Hum Genet 1993;53:670-5.
10. Greenberg DA, Delgado-Escueta AV, Widelitz H, Sparkes RS, et al. Juvenile myoclonic epilepsy may be linked to the BF and HLA loci in human chromosome 6. Am J Med Genet 1988; 31:185-92.
11. Whitehouse WP, Rees M, Curtis D, Sundqvist A, Gardiner RM. Linkage analysis of idiopathic generalised epilepsy and marked loci on chromosome 6p in families of patients with JME: no evidence of an epilepsy locus in the HLA region. Am J Med Grenet 1993;38:652-62.
12. Malafosse A, Lehesjoki AE, Genton P, Labauge P, et al. Identical genetic locus for Baltic and Mediterranean myoclonus. Lancet 1992;339:1080-1.
13. Panayiotopoulos CP, Obeid T, Waheed G. Differentiation of typical absence seizures in epileptic syndromes. A video EEG study of 224 seizures in 20 patients. Brain 1989;112:1039-57.
14. Panayiotopoulos CP. The clinical spectrum of typical absence seizures and absence epilepsies. In: Malafosse A, Genton P, Hirsch E, Marescaux C, et al (eds). Idiopathic generalized epilepsies: clinical, experimental and genetic aspects. London: John Libbey & Co, 1994:75-85.
15. Tassinari CA, Michelucci R, Rubboli G, Passarelli D, et al. Myoclonic absence epilepsy. In: Duncan JS, Panayiotopoulos CP (eds). Typical absences and related epileptic syndromes. London: Churchill Livingstone, 1995:187-95.
16. Appleton RE. Eyelid myoclonia with absences. In: Duncan JS, Panayiotopoulos CP (eds). Typical absences and related epileptic syndromes. London: Churchill Livingstone, 1995:213-20.
17. First seizure trial group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 1993;43:478-83.
18. Richens A, Davidson DL, Cartlidge NE, Easter DJ. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. J Neurol Neurosurg Psychiatry 1994;57:682-7.
19. Heller AJ, Chesterman P, Elwes RD, Crawford P, et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 1995;58:44-50.
20. Verity CM, Hosking G, Easter DJ, on behalf of the Paediatric EPITEG Collaborative Group. A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. Dev Med Child Neurol 1995;37:97-108.
21. Jeavons PM, Clerk JE, Maheshwari MC. Treatment of generalised epilepsies of childhood with sodium valproate. Dev Med Child Neurol 1977;19:9-25.
22. Oheid T. Clinical and genetic aspects of juvenile absence epilepsy. J Neurol 1994;241:487-91.
23. Liporace JD, Sperling MR, Dichter MA. Absence seizures and carbamazepine in adults. Epilepsia 1994;35:1026-8.
24. Manonmani V, Wallace SJ. Epilepsy with myoclonic absences. Arch Dis Child 1994;70:288-90.
25. Brodie MJ. The treatment of typical absences and related epileptic syndromes - consensus statement. In: Duncan JS. Panayiotopoulos CP (eds). Typical absences and related epileptic syndromes. London: Churchill Livingstone, 1995:381-3.
26. Panayiotopoulos CP, Ferrie CD, Giannakodimos S, Robinson RO. Perioral myoclonia with absences. In: Duncan JS, Panayiotopoulos CP (eds). Typical absences and related epileptic syndromes. London: Churchill Livingstone, 1995:221-30.
27. Chadwick D. Epilepsy octet: diagnosis of epilepsy, Lancet 1990;336:291-5.